Page 29 - MemoriaDEM-Eng

www.ciberdem.org

CIBERDEM and EU Funded Projects

áí
í

TELEMEDICINE STUDY

http://www.ciberdem.org/estudio_telemed_diabetes.php

ííí

The Telemed-diabetes study developed by CIBERDEM is a multicentre study in-
cluding the participation of Hospital Clínic de Barcelona, Hospital Carlos Haya de í

Mlaga, Hospital Clnico de Madrid, Hospital de Cruces de Barakaldo and Hospital

Clnico de Valencia, under the leadership of the Director of ISCIII.

CIBERDEM Groups: Dr. Rafael Carmena, Dr. Ramon Gomis, Dr. Manuel Serrano
Ros, Dr. Federico Soriguer and Dr. Luis Castaño.

The main objective of the project is to assess the impact of the Medical Guard Dia- á

betes® telematic system on the efficiency of clinical and economic management of

human resources and materials intended for a programme for optimizing metabolic
control in patients with type 1 diabetes mellitus (DM1), taking into consideration

the degree of metabolic control and quality of life of the patients. This telematic
communication system allows transmitting results of capillary blood glucose, in-

sulin dose, carbohydrate intake during meals and other events from the patient’s

home or anywhere else to the medical team through a web server

Patient inclusion took place between May and October 2011 and patient follow-up
ended in April 2012. The results were analyzed in 2013 and a scientific report was

prepared.

The distribution of patients per centre is as follows:

• Hospital Carlos Haya de Mlaga: 34 patients
13
• Hospital Clnic de Barcelona: 33 patients 20
T
• Hospital de Cruces Barakaldo: 32 patients OR
P
• Hospital Clnico de Valencia:
29 patients RE
L
• Hospital Clnico de Madrid:
25 patients
A
NU
N
A
The evolution of the metabolic control data, economic patient and medical equip- M /
E
ment costs, the knowledge, quality of life and compliance with treatment corres- D
ER
ponding to the follow-up of two groups of patients were studied:
B
CI

29